TRVI - Trevi Therapeutics Inc. (TRVI) CEO Jennifer Good on Q4 2020 Results - Earnings Call Transcript

Trevi Therapeutics, Inc. (TRVI) Q4 2020 Earnings Conference Call March 25, 2021 4:30 PM ET Company Participants Jennifer Good - President and CEO Chris Seiter - Chief Financial Officer Bill Forbes - Chief Development Officer Conference Call Participants Gary Nachman - BMO Capital Markets Annabel Samimy - Stifel Serge Belanger - Needham & Company Presentation Operator Good afternoon, and welcome to the Trevi Therapeutics Year End 2020 Earnings Conference Call [Operator Instructions]. As a reminder, this call may be recorded. Various remarks that management makes during this call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risks Factors section of the company's most recent annual report on

For further details see:

Trevi Therapeutics, Inc. (TRVI) CEO Jennifer Good on Q4 2020 Results - Earnings Call Transcript